Morgan Stanley Celularity Inc Transaction History

Morgan Stanley

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Aug 16, 2024	BUY	$0.17 - $0.33 $8,722 - $16,930	51,306 New	51,306 $12,000
Q4 2023 Feb 13, 2024	SELL	$0.17 - $0.33 $4,906 - $9,523	-28,859 Reduced 36.0%	51,306 $12,000
Q3 2023 Nov 15, 2023	SELL	$0.22 - $0.56 $5,351 - $13,622	-24,325 Reduced 23.28%	80,165 $17,000
Q2 2023 Aug 14, 2023	BUY	$0.42 - $0.81 $19,898 - $38,375	47,377 Added 82.95%	104,490 $55,000
Q1 2023 May 15, 2023	SELL	$0.56 - $1.15 $7,790 - $15,998	-13,912 Reduced 19.59%	57,113 $35,000
Q4 2022 Feb 14, 2023	SELL	$1.08 - $2.35 $31,232 - $67,959	-28,919 Reduced 28.94%	71,025 $91,000
Q3 2022 Nov 14, 2022	BUY	$0.43 - $4.31 $10,006 - $100,298	23,271 Added 30.35%	99,944 $230,000
Q2 2022 Oct 27, 2022	BUY	$2.81 - $12.91 $75,282 - $345,871	26,791 Added 53.71%	76,673 $260,000
Q2 2022 Aug 15, 2022	BUY	$2.81 - $12.91 $75,282 - $345,871	26,791 Added 53.71%	76,673 $260,000
Q1 2022 Oct 27, 2022	SELL	$3.81 - $9.79 $102,073 - $262,283	-26,791 Reduced 34.94%	49,882 $435,000
Q1 2022 May 13, 2022	SELL	$3.81 - $9.79 $552 - $1,419	-145 Reduced 0.29%	49,882 $435,000
Q4 2021 Feb 14, 2022	SELL	$4.64 - $7.46 $4,514 - $7,258	-973 Reduced 1.91%	50,027 $256,000
Q3 2021 Nov 15, 2021	BUY	$6.05 - $12.15 $308,550 - $619,650	51,000 New	51,000 $361,000

23.6M

Ticker CELU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,424,000
Market Cap $319M
Description
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-de...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.